Natalya Davies
Stock Analyst at Rothschild & Co Redburn
(3.00)
# 2,569
Out of 4,579 analysts
9
Total ratings
77.8%
Success rate
14.2%
Average return
Main Sectors:
Stocks Rated by Natalya Davies
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRK Merck & Co. | Maintained: Buy | $179 | $130.76 | +36.89% | 1 | Apr 17, 2026 | |
| RGEN Repligen | Initiated Coverage: Buy | $160 | $131.06 | +22.08% | 1 | Apr 17, 2026 | |
| TMO Thermo Fisher Scientific | Maintained: Buy | $575 → $620 | $559.53 | +10.81% | 2 | Apr 17, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Maintained: Buy | €285.00 | €214.30 | +32.99% | 1 | Apr 17, 2026 | |
| BRKR Bruker | Maintained: Buy | $60 | $60.05 | -0.08% | 2 | Nov 20, 2025 | |
| A Agilent Technologies | Initiated Coverage: Buy | $165 | $137.89 | +19.66% | 1 | Oct 8, 2025 | |
| WAT Waters | Initiated Coverage: Buy | $390 | $371.20 | +5.06% | 1 | Oct 8, 2025 |
Merck & Co.
Apr 17, 2026
Maintained: Buy
Price Target: $179
Current: $130.76
Upside: +36.89%
Repligen
Apr 17, 2026
Initiated Coverage: Buy
Price Target: $160
Current: $131.06
Upside: +22.08%
Thermo Fisher Scientific
Apr 17, 2026
Maintained: Buy
Price Target: $575 → $620
Current: $559.53
Upside: +10.81%
Sartorius Aktiengesellschaft
Apr 17, 2026
Maintained: Buy
Price Target: €285.00
Current: €214.30
Upside: +32.99%
Bruker
Nov 20, 2025
Maintained: Buy
Price Target: $60
Current: $60.05
Upside: -0.08%
Agilent Technologies
Oct 8, 2025
Initiated Coverage: Buy
Price Target: $165
Current: $137.89
Upside: +19.66%
Waters
Oct 8, 2025
Initiated Coverage: Buy
Price Target: $390
Current: $371.20
Upside: +5.06%